Work

Corrigendum to ‘Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial’ [Vaccine 36 (2018) 4278–4286]

Year: 2019

Type: erratum

Abstract: The authors regret an error in the footnote of Table 2: the adjusted GMC values were not only adjusted for baseline value, but also for age.The authors would like to

Source: Vaccine

DOI: 10.1016/j.vaccine.2019.01.022

Authors: Céline Maréchal, Himal Lal, Airi Poder, Murdo Ferguson, Igwebuike Enweonye, Thomas C. Heineman, Caroline Hervé, Paul Rheault, Jaak Talli, Dominique Wauters, Lidia Oostvogels

Institutions: GlaxoSmithKline (Belgium), GlaxoSmithKline (United States), Tartu University Hospital

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $2,450

OpenAlex ID: W2912406697

Cites:

Cited by:

Related to: 10